Wednesday, June 10, 2026

biotech Β· Breast Cancer Β· Pleural carcinosis Β· SANA

Sana Biotechnology

Sana Biotechnology clinical programs β€” 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

188 E Blaine St, Suite 400, Seattle, Washington 98102, US HQ
2018 Founded
265 Employees
Public company Type
SANA Β· NYSE Ticker
Company details
Status
Public
HQ
188 E Blaine St, Suite 400, Seattle, Washington 98102, US
Founded
2018
Employees
265
Programs
19
Drugs
21
Patents
136
Intelligence Β· Clinical Programs

Sana Biotechnology projects

1 ClinicalTrials.gov programs sponsored by Sana Biotechnology.

Sana Biotechnology has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Sodio ioduro (I131) Curium Netherlands 37-740...

    Sana Biotechnology

    Graves' disease and Graves' orbitophaty

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Sana Biotechnology have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.